Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Voogt

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1989
Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytesP J Voogt, J H Falkenburg, W E Fibbe, et al.
Blood|July 1, 1989
Lymphokine-activated killer cells selectively kill tumor cells in bone marrow without compromising bone marrow stem cell function in vitroM R van den Brink, P J Voogt, W A Marijt, et al.
Blood|October 1, 1988
Proliferation of myeloid progenitor cells in human long-term bone marrow cultures is stimulated by interleukin-1 betaW E Fibbe, H M Goselink, G Van Eeden, et al.
Cancer|February 15, 1987
Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patientsP J Voogt, C J van de Velde, A Brand, et al.
Blood|February 1, 1988
Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factorW E Fibbe, J van Damme, A Billiau, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Generation of donor-derived antileukemic cytotoxic T-lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantationJ H Falkenburg, L M Faber, M van den Elshout, et al.
Lancet (London, England)|January 20, 1990
Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigensP J Voogt, W E Fibbe, W A Marijt, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1989
Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytesP J Voogt, J H Falkenburg, W E Fibbe, et al.
Blood|July 1, 1989
Lymphokine-activated killer cells selectively kill tumor cells in bone marrow without compromising bone marrow stem cell function in vitroM R van den Brink, P J Voogt, W A Marijt, et al.
Blood|October 1, 1988
Proliferation of myeloid progenitor cells in human long-term bone marrow cultures is stimulated by interleukin-1 betaW E Fibbe, H M Goselink, G Van Eeden, et al.
Cancer|February 15, 1987
Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patientsP J Voogt, C J van de Velde, A Brand, et al.
Blood|February 1, 1988
Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factorW E Fibbe, J van Damme, A Billiau, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Generation of donor-derived antileukemic cytotoxic T-lymphocyte responses for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantationJ H Falkenburg, L M Faber, M van den Elshout, et al.
Lancet (London, England)|January 20, 1990
Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigensP J Voogt, W E Fibbe, W A Marijt, et al.
Pageof 2